vs
AMN HEALTHCARE SERVICES INC（AMN）与科睿唯安（CLVT）财务数据对比。点击上方公司名可切换其他公司
AMN HEALTHCARE SERVICES INC的季度营收约是科睿唯安的1.2倍（$748.2M vs $617.0M），科睿唯安净利率更高（0.5% vs -1.0%，领先1.5%），AMN HEALTHCARE SERVICES INC同比增速更快（1.8% vs -6.9%），科睿唯安自由现金流更多（$89.2M vs $67.6M），过去两年科睿唯安的营收复合增速更高（-0.3% vs -4.5%）
AMN医疗保健服务公司是美国领先的医疗人力资源解决方案提供商，主要为医院、诊所等各类医疗机构提供护士、医师、医技人员及其他临床、非临床岗位的临时与长期派遣服务，同时提供医护团队管理技术支持及相关咨询服务。
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
AMN vs CLVT — 直观对比
营收规模更大
AMN
是对方的1.2倍
$617.0M
营收增速更快
AMN
高出8.8%
-6.9%
净利率更高
CLVT
高出1.5%
-1.0%
自由现金流更多
CLVT
多$21.6M
$67.6M
两年增速更快
CLVT
近两年复合增速
-4.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $748.2M | $617.0M |
| 净利润 | $-7.7M | $3.1M |
| 毛利率 | 26.1% | 66.8% |
| 营业利润率 | 1.1% | 6.7% |
| 净利率 | -1.0% | 0.5% |
| 营收同比 | 1.8% | -6.9% |
| 净利润同比 | 95.9% | 101.6% |
| 每股收益（稀释后） | $-0.19 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMNCLVT
| Q4 25 | $748.2M | $617.0M | ||
| Q3 25 | $634.5M | $623.1M | ||
| Q2 25 | $658.2M | $621.4M | ||
| Q1 25 | $689.5M | $593.7M | ||
| Q4 24 | $734.7M | $663.0M | ||
| Q3 24 | $687.5M | $622.2M | ||
| Q2 24 | $740.7M | $650.3M | ||
| Q1 24 | $820.9M | $621.2M |
净利润AMNCLVT
| Q4 25 | $-7.7M | $3.1M | ||
| Q3 25 | $29.3M | $-28.3M | ||
| Q2 25 | $-116.2M | $-72.0M | ||
| Q1 25 | $-1.1M | $-103.9M | ||
| Q4 24 | $-187.5M | $-191.8M | ||
| Q3 24 | $7.0M | $-65.6M | ||
| Q2 24 | $16.2M | $-304.3M | ||
| Q1 24 | $17.3M | $-75.0M |
毛利率AMNCLVT
| Q4 25 | 26.1% | 66.8% | ||
| Q3 25 | 29.1% | 65.0% | ||
| Q2 25 | 29.8% | 67.2% | ||
| Q1 25 | 28.7% | 65.1% | ||
| Q4 24 | 29.8% | 65.7% | ||
| Q3 24 | 31.0% | 66.2% | ||
| Q2 24 | 31.0% | 67.2% | ||
| Q1 24 | 31.4% | 64.9% |
营业利润率AMNCLVT
| Q4 25 | 1.1% | 6.7% | ||
| Q3 25 | 7.5% | 7.1% | ||
| Q2 25 | -18.8% | 1.1% | ||
| Q1 25 | 1.8% | -3.5% | ||
| Q4 24 | -27.6% | -9.4% | ||
| Q3 24 | 3.2% | 3.5% | ||
| Q2 24 | 5.1% | -36.9% | ||
| Q1 24 | 4.9% | 0.8% |
净利率AMNCLVT
| Q4 25 | -1.0% | 0.5% | ||
| Q3 25 | 4.6% | -4.5% | ||
| Q2 25 | -17.7% | -11.6% | ||
| Q1 25 | -0.2% | -17.5% | ||
| Q4 24 | -25.5% | -28.9% | ||
| Q3 24 | 1.0% | -10.5% | ||
| Q2 24 | 2.2% | -46.8% | ||
| Q1 24 | 2.1% | -12.1% |
每股收益（稀释后）AMNCLVT
| Q4 25 | $-0.19 | $0.00 | ||
| Q3 25 | $0.76 | $-0.04 | ||
| Q2 25 | $-3.02 | $-0.11 | ||
| Q1 25 | $-0.03 | $-0.15 | ||
| Q4 24 | $-4.90 | $-0.27 | ||
| Q3 24 | $0.18 | $-0.09 | ||
| Q2 24 | $0.42 | $-0.46 | ||
| Q1 24 | $0.45 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.0M | $329.2M |
| 总债务越低越好 | $767.1M | $4.3B |
| 股东权益账面价值 | $642.1M | $4.8B |
| 总资产 | $2.1B | $11.1B |
| 负债/权益比越低杠杆越低 | 1.19× | 0.89× |
8季度趋势，按日历期对齐
现金及短期投资AMNCLVT
| Q4 25 | $34.0M | $329.2M | ||
| Q3 25 | $52.6M | $318.7M | ||
| Q2 25 | $41.5M | $362.6M | ||
| Q1 25 | $55.8M | $354.0M | ||
| Q4 24 | $10.6M | $295.2M | ||
| Q3 24 | $30.6M | $388.5M | ||
| Q2 24 | $48.0M | $376.4M | ||
| Q1 24 | $50.6M | $361.8M |
总债务AMNCLVT
| Q4 25 | $767.1M | $4.3B | ||
| Q3 25 | — | $4.4B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.5B | ||
| Q4 24 | $1.1B | $4.5B | ||
| Q3 24 | — | $4.6B | ||
| Q2 24 | — | $4.6B | ||
| Q1 24 | — | $4.6B |
股东权益AMNCLVT
| Q4 25 | $642.1M | $4.8B | ||
| Q3 25 | $644.4M | $4.9B | ||
| Q2 25 | $607.6M | $5.0B | ||
| Q1 25 | $715.1M | $5.0B | ||
| Q4 24 | $706.6M | $5.1B | ||
| Q3 24 | $890.7M | $5.5B | ||
| Q2 24 | $876.9M | $5.6B | ||
| Q1 24 | $854.2M | $5.9B |
总资产AMNCLVT
| Q4 25 | $2.1B | $11.1B | ||
| Q3 25 | $2.1B | $11.2B | ||
| Q2 25 | $2.2B | $11.4B | ||
| Q1 25 | $2.4B | $11.5B | ||
| Q4 24 | $2.4B | $11.5B | ||
| Q3 24 | $2.7B | $12.0B | ||
| Q2 24 | $2.8B | $12.1B | ||
| Q1 24 | $2.9B | $12.5B |
负债/权益比AMNCLVT
| Q4 25 | 1.19× | 0.89× | ||
| Q3 25 | — | 0.90× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | 1.49× | 0.88× | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | — | 0.79× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $75.6M | $159.9M |
| 自由现金流经营现金流 - 资本支出 | $67.6M | $89.2M |
| 自由现金流率自由现金流/营收 | 9.0% | 14.5% |
| 资本支出强度资本支出/营收 | 1.1% | 11.5% |
| 现金转化率经营现金流/净利润 | — | 51.58× |
| 过去12个月自由现金流最近4个季度 | $233.8M | $365.3M |
8季度趋势，按日历期对齐
经营现金流AMNCLVT
| Q4 25 | $75.6M | $159.9M | ||
| Q3 25 | $22.7M | $181.1M | ||
| Q2 25 | $78.5M | $116.3M | ||
| Q1 25 | $92.7M | $171.2M | ||
| Q4 24 | $72.8M | $141.3M | ||
| Q3 24 | $66.7M | $202.9M | ||
| Q2 24 | $99.5M | $126.2M | ||
| Q1 24 | $81.4M | $176.2M |
自由现金流AMNCLVT
| Q4 25 | $67.6M | $89.2M | ||
| Q3 25 | $14.8M | $115.5M | ||
| Q2 25 | $68.7M | $50.3M | ||
| Q1 25 | $82.7M | $110.3M | ||
| Q4 24 | $56.6M | $59.1M | ||
| Q3 24 | $47.4M | $126.3M | ||
| Q2 24 | $72.2M | $60.3M | ||
| Q1 24 | $63.2M | $111.8M |
自由现金流率AMNCLVT
| Q4 25 | 9.0% | 14.5% | ||
| Q3 25 | 2.3% | 18.5% | ||
| Q2 25 | 10.4% | 8.1% | ||
| Q1 25 | 12.0% | 18.6% | ||
| Q4 24 | 7.7% | 8.9% | ||
| Q3 24 | 6.9% | 20.3% | ||
| Q2 24 | 9.8% | 9.3% | ||
| Q1 24 | 7.7% | 18.0% |
资本支出强度AMNCLVT
| Q4 25 | 1.1% | 11.5% | ||
| Q3 25 | 1.2% | 10.5% | ||
| Q2 25 | 1.5% | 10.6% | ||
| Q1 25 | 1.4% | 10.3% | ||
| Q4 24 | 2.2% | 12.4% | ||
| Q3 24 | 2.8% | 12.3% | ||
| Q2 24 | 3.7% | 10.1% | ||
| Q1 24 | 2.2% | 10.4% |
现金转化率AMNCLVT
| Q4 25 | — | 51.58× | ||
| Q3 25 | 0.77× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 9.54× | — | ||
| Q2 24 | 6.13× | — | ||
| Q1 24 | 4.70× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMN
| Travel Nurse Staffing | $208.3M | 28% |
| Allied Staffing | $146.9M | 20% |
| Labor Disruption Services | $124.3M | 17% |
| Technology And Workforce Solutions | $88.0M | 12% |
| Language Services | $69.9M | 9% |
| Other | $29.6M | 4% |
| International Nurse Staffing | $29.6M | 4% |
| Interim Leadership Staffing | $24.1M | 3% |
| Vendor Management Systems | $16.3M | 2% |
| Local Staffing | $8.6M | 1% |
| International Nurse Permanent Placement | $2.6M | 0% |
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
